Current Price
Biotech Acquisition Company is a blank check company. The company is headquartered in New York, New York.
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
No peer comparison data available for this company.
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Sep 20 | Mar 21 | Jun 21 | Sep 21 | Dec 21 | Mar 22 | Jun 22 | Sep 22 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COGS | 0 | 0.15 | 0.46 | 0.63 | 0.33 | 1.9 | 1.26 | 0.25 |
Gross Profit | 0 | -0.15 | -0.46 | -0.63 | -0.33 | -1.9 | -1.26 | -0.25 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 0 | 0.15 | 0.46 | 0.63 | 0.33 | 1.9 | 1.26 | 0.25 | |
EBIT | -0.01 | -0.15 | -0.46 | -0.63 | -0.33 | -1.9 | -1.26 | -0.25 |
OPM % | - | - | - | - | - | - | - | - |
Non-Operating Income | 0 | 2.69 | -4.6 | 3.57 | -4.01 | 6.57 | 10.65 | 1.51 |
PBT | -0.01 | 2.55 | -5.07 | 2.94 | -4.34 | 4.68 | 9.38 | 1.26 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | - | - | - | - | - | - | - | - |
Net Income | -0.01 | 2.55 | -5.07 | 2.94 | -4.34 | 4.68 | 9.38 | 1.26 |
NPM % | - | - | - | - | - | - | - | - |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2020 | Dec 2021 |
|---|---|---|
Revenue | 0 | 0 |
COGS | 0 | 1.57 |
Gross Profit | 0 | -1.57 |
Gross Profit % | - | - |
| 0 | 1.57 | |
EBIT | -0.01 | -1.57 |
OPM % | - | - |
Non-Operating Income | 0 | -5.29 |
PBT | -0.01 | -6.86 |
Income Tax | 0 | 0 |
Tax Rate % | - | - |
Net Income | -0.01 | -6.86 |
NPM % | - | - |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2020 | Dec 2021 |
|---|---|---|
| 0 | 0 | |
| 0 | 230.02 | |
| 0 | 0 | |
| 0.09 | 0 | |
| 0 | -230.02 | |
Total Assets | 0.09 | 0 |
| 0 | 0 | |
| 0.02 | -0 | |
| 0.14 | 0 | |
| 0.07 | 0.31 | |
| -0.14 | -0.31 | |
Total Liabilities | 0.09 | 0 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2020 | Dec 2021 |
|---|---|---|
| 0 | -1.47 | |
| 0 | -230 | |
| 0 | 231.56 | |
Net CFNet Cash Flow | 0 | 0.09 |
FCFFree Cash Flow | 0 | -1.47 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2020 | Dec 2021 |
|---|---|---|
| - | -68739.2% | |
| 3.48 | - | |
| 1.29 | 0.97 | |
| - | 0.00 | |
Cash Conversion | - | 0.21 |
Payout Ratio | - | - |
| - | - | |
| - | - | |
| - | - | |
| 2.00 | 3.00 | |
| - | - | |
| 0.00 | - | |
| - | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns Instinct Bio Technical Company Holdings Inc - Warrants (14/07/2031), from SEC filings
No SEC ownership filings for this company yet.
Instinct Bio Technical Company Holdings Inc - Warrants (14/07/2031)'s SEC filings and earnings call transcripts
No SEC filings for this company yet.
What recent news says about Instinct Bio Technical Company Holdings Inc - Warrants (14/07/2031), scored for sentiment.